Ose Immunotherapeutics SA (OSE) Stock Price & News

All values in EUR	2024 ж. қыр.	2024 ж. жел.
Revenue	431,00 м.	431,00 м.
Cost of goods sold	-	-
Cost of revenue	-	-
Research and development expenses	8,28 млн	8,28 млн
Total research and development expenses	-	-
Selling, general, and admin expenses	1,08 млн	1,08 млн
Operating expense	10,22 млн	10,22 млн
Total operating expenses	10,22 млн	10,22 млн
Operating income	-9,79 млн	-9,79 млн
Other non operating income	-611,00 м.	-611,00 м.
EBT including unusual items	-10,44 млн	-10,44 млн
EBT excluding unusual items	-10,53 млн	-10,53 млн
Income tax expense	-576,50 м.	-576,50 м.
Effective tax rate	5,52%	5,52%
Other operating expenses	41,00 мың	41,00 мың
Net income	-9,86 млн	-9,86 млн
Net profit margin	-2 288,86%	-2 288,86%
Earnings per share	-	-
Interest and investment income	571,00 м.	571,00 м.
Interest expense	-707,50 м.	-707,50 м.
Net interest expenses	-136,50 м.	-136,50 м.
Depreciation and amortization charges	-	-
EBITDA	-9,74 млн	-9,74 млн
Gain or loss from assets sale	-	-

Ask anything